R/R HR-MDS

Clinical trials for R/R HR-MDS explained in plain language.

Never miss a new study

Get alerted when new R/R HR-MDS trials appear

Sign up with your email to follow new studies for R/R HR-MDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New antibody GEN3018 tested in first human trial for relapsed blood cancers

Disease control Recruiting now

This study tests a new drug called GEN3018 in people whose acute myeloid leukemia (AML) or higher-risk myelodysplastic syndrome (MDS) has returned or not responded to treatment. The main goal is to check safety and find the best dose. Up to 78 adults will receive the drug, and th…

Matched conditions: R/R HR-MDS

Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control

Last updated Jun 16, 2026 12:50 UTC

R/R HR-MDS

Get alerted when new R/R HR-MDS trials appear

New antibody GEN3018 tested in first human trial for relapsed blood cancers